Other psoriatic arthropathies

PSOR_ARTHR_OTH

psoriatic arthritis: Joint inflammation associated with psoriasis.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — M07.3, M07.3L40.5 Cause of death: ICD-10 — M07.3, M07.3L40.5 2 out of 7 registries used, show all original rules.	4160
4. Check minimum number of events None	4160
5. Include endpoints None	4160
6. Filter based on genotype QC (FinnGen only)	4160

Control definitions (FinnGen only)

Control exclude: PSOR_ENTE_ARTHR

Extra metadata

First used in FinnGen datafreeze: DF2

NAME	PSOR_ARTHR_OTH
CONTROL_EXCLUDE	PSOR_ENTE_ARTHR
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	M073
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	M073
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other psoriatic arthropathies based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Psoriatic arthropathies, strict definition

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	4160	2321	1839
Unadjusted period prevalence (%)	0.80	0.79	0.81
Median age at first event (years)	52.05	51.73	52.46

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3796: Matched controls
37961

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

L40.0

ICD-10 Finland

Psoriasis vulgaris

47.6

323.0

1680

623

L04AB04

ATC

adalimumab; parenteral

32.2

323.0

628

232

E0000UV

ATC

4.6

323.0

2361

10060

M07.3

ICD-10 Finland

Other psoriatic arthropathies

4364.3

323.0

1651

D05AX02

ATC

calcipotriol; topical

39.3

323.0

1412

563

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

36.2

323.0

904

325

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

21.5

323.0

1509

1131

D05BB02

ATC

acitretin; oral

20.3

323.0

558

319

D07XC01

ATC

betamethasone, combinations; topical

15.5

323.0

1942

2394

D07AD01

ATC

clobetasol; topical

6.7

323.0

1495

3333

L04AA13

ATC

leflunomide; oral

31.1

323.0

760

303

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

35.1

323.0

919

342

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

7.8

323.0

971

1607

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

24.2

323.0

1598

1105

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

72.8

323.0

2913

1641

H02AB06

ATC

prednisolone; systemic

4.2

323.0

2567

12559

L88

ICPC

Rheumatoid/seropositive arthritis

17.7

323.0

730

505

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

63.3

323.0

2960

2010

D05AX52

ATC

calcipotriol, combinations; topical

40.9

323.0

1864

873

L40.5

ICD-10 Finland

Arthropathic psoriasis

778.3

323.0

2190

E000001

ATC

4.8

323.0

1498

4508

M07.0*L40.5

ICD-10 Finland

Distal interphalangeal psoriatic arthropathy

3568.1

323.0

337

M07.3*L40.5

ICD-10 Finland

Other psoriatic arthropathies

16384.0

323.0

3553

D07AC01

ATC

betamethasone; topical

6.3

323.0

2434

8427

A07EC01

ATC

sulfasalazine; oral, rectal

25.3

323.0

1862

1392

D05AX03

ATC

calcitriol; topical

36.7

323.0

488

152

L01BA01

ATC

methotrexate; systemic (folic acid analog.)

33.8

323.0

1204

515

D07AC13

ATC

mometasone; topical

3.9

307.1

1818

7299

L04AB01

ATC

etanercept; parenteral

27.1

302.5

425

176

M13.9

ICD-10 Finland

Arthritis, unspecified

7.5

296.8

769

1242

S91

ICPC

Psoriasis

68.3

292.1

337

L40

ICD-10 Finland

Psoriasis

22.9

291.6

431

211

319

Kela drug reimbursment

Adalimumab, brodalumab, certolizumab pegol, etanercept, guselkumab, infliximab, ixekizumab, risankizumab, sekukinumab and ustekinumab (skin psoriasis)

68.4

252.2

291

L40.9

ICD-10 Finland

Psoriasis, unspecified

22.7

252.1

373

181

L04AC10

ATC

secukinumab; parenteral

142.9

251.1

266

D07AB02

ATC

hydrocortisone butyrate; topical

3.3

232.3

1579

6662

377

Kela drug reimbursment

Apremilast and dimethyl fumarate (psoriasis)

227.6

229.5

235

P01BA02

ATC

hydroxychloroquine; oral

5.4

203.1

682

1487

6960A

ICD-9 Finland

Psoriasis and similar disorders, Psoriatic arthropathy

+∞

197.6

188

E000002

ATC

4.3

190.5

806

2227

L04AA32

ATC

apremilast; oral

203.2

186.9

193

L40.8

ICD-10 Finland

Other psoriasis

33.1

184.5

245

M07.0

ICD-10 Finland

Distal interphalangeal psoriatic arthropathy

623.9

182.2

179

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

4.8

178.0

659

1583

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.7

174.4

1979

11024

E000003

ATC

6.6

166.6

459

771

L04AC13

ATC

ixekizumab; parenteral

247.8

162.7

166

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

2.9

160.8

1249

5452

NH3EA

NOMESCO Finland

Feet X-ray examination with load

11.6

157.3

304

283

D05AA

ATC

Tars

39.6

156.3

199

M25.5

ICD-10 Finland

Pain in joint

2.7

151.3

1452

7160

M01AH05

ATC

etoricoxib; oral

2.5

151.3

2660

18218

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

6.0

150.9

447

821

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

11.1

142.3

281

272

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

10.1

139.4

289

307

M07.2*L40.5

ICD-10 Finland

Psoriatic spondylitis

1396.1

138.4

134

L04AD01

ATC

ciclosporin; systemic

11.1

137.8

272

263

L04AB06

ATC

golimumab; parenteral

25.3

133.4

190

M01AH01

ATC

celecoxib; oral (coxibs)

2.8

122.6

956

4061

D02AE01

ATC

carbamide; topical

4.5

122.2

479

1191

M01AC06

ATC

meloxicam; systemic, rectal

2.3

119.5

1686

9834

TND11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in joint, wrist or hand

13.5

119.2

213

166

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

8.2

117.9

275

356

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.4

115.4

1380

7391

L04AC05

ATC

ustekinumab; parenteral

44.6

114.5

142

WXQ27

NOMESCO Finland

UVB narrow spectrum light therapy

12.7

114.3

210

174

L04AA01

ATC

[U] ciclosporin; systemic

11.9

111.6

211

186

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

9.7

110.7

233

253

69619

ICD-8 Finland

Psoriasis and similar disorders, Psoriasis alia sive NUD (vulgaris)

48.2

110.5

135

299

Kela drug reimbursment

1078.3

107.9

105

TNG10

NOMESCO Finland

Puncture of knee

15.0

107.2

183

128

D07AB08

ATC

desonide; topical

3.3

106.4

598

2013

ND2BA

NOMESCO Finland

Hand and fingers extensive X-ray examination

8.1

101.7

238

309

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

11.1

97.9

192

182

H02AB07

ATC

prednisone; oral

2.8

93.2

711

2921

L40.3

ICD-10 Finland

Pustulosis palmaris et plantaris

10.8

91.3

181

175

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

7.0

90.3

235

357

M01CB03

ATC

auranofin; oral

20.5

89.2

135

134

Kela drug reimbursment

General erythroderma

32.6

88.3

117

TNH11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in ankle joint or foot joint

12.3

87.3

162

137

L40.4

ICD-10 Finland

Guttate psoriasis

26.3

85.6

120

L20

ICPC

Joint symptom/complaint NOS

5.5

85.2

265

507

WZA10

NOMESCO Finland

Long statement of health and health related matters

10.6

84.6

169

166

M01AE02

ATC

naproxen; oral, rectal

2.0

83.6

2286

16581

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

3.4

83.2

449

1449

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

3.2

83.1

494

1712

L04AB05

ATC

certolizumab pegol; parenteral

38.5

82.4

105

E000006

ATC

3.6

82.3

410

1242

TQW80

NOMESCO Finland

Local dermatologic skincare

6.3

82.1

229

382

6961A

ICD-9 Finland

Psoriasis and similar disorders, Other psoriasis[PSORIASIS VULGARIS]

52.9

81.8

M45

ICD-10 Finland

Ankylosing spondylitis

6.9

80.2

208

314

M01CB01

ATC

sodium aurothiomalate; parenteral

10.9

78.2

154

147

291

Kela drug reimbursment

Tofacitinib

57.6

76.2

ZX140

NOMESCO Finland

Intra articular

15.6

76.1

127

69600

ICD-8 Finland

Psoriasis and similar disorders, Psoriatic arthropathy

+∞

75.2

A02BC02

ATC

pantoprazole; systemic

1.9

73.2

2498

19157

D05AX05

ATC

tazarotene; topical

66.0

72.7

L04AA11

ATC

[U] etanercept; parenteral

29.0

72.7

N02AX02

ATC

tramadol; systemic, rectal

1.9

71.0

1674

11236

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

3.4

69.0

368

1170

NG1DA

NOMESCO Finland

X-ray of knees

7.7

69.0

166

224

TNG11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in knee

14.4

67.3

116

J01DB01

ATC

cefalexin; oral

2.1

66.9

3153

26677

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.8

66.2

1624

10966

L04AA29

ATC

tofacitinib; oral

40.4

65.9

E000007

ATC

3.5

64.7

326

990

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.6

63.5

530

2251

3005

Kela drug reimbursment

Tofacitinib

48.4

62.6

R4120

NOMESCO Finland

Occupational therapy

3.3

62.4

342

1108

M01AH02

ATC

rofecoxib; oral

2.4

61.7

575

2590

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.7

60.9

447

1759

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.8

60.4

1823

13028

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

4.2

60.3

240

594

ZXX01

NOMESCO Finland

Extent of proceudre, 1 unit

11.7

59.9

113

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

4.9

57.7

197

417

N02BE01

ATC

paracetamol; systemic, rectal

2.0

56.8

3229

28016

M46.9

ICD-10 Finland

Inflammatory spondylopathy, unspecified

8.9

52.7

115

133

L04AC16

ATC

guselkumab; systemic

67.6

52.3

NG1AE

NOMESCO Finland

Knee joint ultrasound exmination

9.2

50.6

108

120

D02AX

ATC

Other emollients and protectives

4.4

50.6

192

453

NK5AT

NOMESCO Finland

Joint injection with ultrasound guidance not elsewhere classified

11.5

49.0

J01FF01

ATC

clindamycin; systemic

1.8

48.5

1076

6840

XX9XE

NOMESCO Finland

Other ultrasound examination

10.0

47.7

ZXX02

NOMESCO Finland

Extent of procedure, 2 units

8.1

47.3

109

138

M07.5*K51.9

ICD-10 Finland

Arthropathy in ulcerative colitis

+∞

47.0

L04AA17

ATC

[U] adalimumab; parenteral

21.0

45.7

N02AJ06

ATC

codeine and paracetamol; systemic

1.7

45.3

1420

9977

M073L

ICD-10 Finland

+∞

44.9

D07BC01

ATC

betamethasone and antiseptics; topical

2.2

44.6

518

2566

NH1AE

NOMESCO Finland

Ankle joint ultrasound examination

11.0

44.4

M01AX17

ATC

nimesulide; oral

1.8

43.5

928

5791

H02AB04

ATC

methylprednisolone; systemic

2.0

43.5

601

3203

D07XB01

ATC

flumetasone, combinations; topical

11.0

43.0

M07.4*K50.9

ICD-10 Finland

Arthropathy in Crohn's disease [regional enteritis]

+∞

42.8

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.3

42.0

432

2020

NA6AA

NOMESCO Finland

Sacro-iliac joint X-ray examination

14.5

41.2

D07AA02

ATC

hydrocortisone; topical

2.1

41.1

537

2793

M01AB05

ATC

diclofenac; systemic, rectal

1.6

40.7

2542

21146

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.7

40.4

1096

7333

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

2.1

39.8

506

2598

M07.1*L40.5

ICD-10 Finland

Arthritis mutilans

+∞

39.6

NGF15

NOMESCO Finland

Total synovectomy of knee, arthroscopic

7.4

39.1

131

Z3231

NOMESCO Finland

Registered nurse

1.7

38.9

1004

6602

M79.0

ICD-10 Finland

Rheumatism, unspecified

3.5

38.7

190

563

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.2

38.1

409

1947

M13.0

ICD-10 Finland

Polyarthritis, unspecified

6.8

37.9

148

D05AC01

ATC

dithranol; topical

46.5

37.9

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.7

36.6

275

1086

XQ848

NOMESCO Finland

Dermatological photography

4.4

36.2

135

314

Z50.1

ICD-10 Finland

Other physical therapy

2.8

36.1

245

909

Z3229

NOMESCO Finland

Other healthcare associate professional

2.4

35.9

340

1523

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.5

35.8

302

1272

SPAT1249

SPAT

Treatment-related counselling outside office

1.6

35.4

1405

10311

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

6.0

35.2

168

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

2.9

35.0

229

832

M07.2

ICD-10 Finland

Psoriatic spondylitis

350.4

35.0

M01AB55

ATC

diclofenac, combinations; oral

2.5

34.8

285

1183

NF1AA

NOMESCO Finland

Hip X-ray examination

2.4

33.8

309

1357

M01AX01

ATC

nabumetone; oral

2.9

33.6

211

746

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.5

33.5

283

1194

R4110

NOMESCO Finland

Physiotherapy

1.6

32.6

951

6417

L99

ICPC

Musculoskeletal disease other

4.6

32.4

115

255

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

4.5

32.2

118

270

J01DA01

ATC

[U] cefalexin; systemic

1.5

32.0

2266

18817

M13.1

ICD-10 Finland

Monoarthritis, not elsewhere classified

7.3

32.0

109

A46

ICD-10 Finland

Erysipelas

1.9

31.8

492

2712

A02BC05

ATC

esomeprazole; systemic

1.5

31.7

1459

11004

I10

ICD-10 Finland

Essential (primary) hypertension

1.5

31.5

1879

15005

WXQ12

NOMESCO Finland

Psoralen - Ultraviolet A therapy with local sensitivisation

12.6

31.2

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.8

31.2

627

3784

M17.5

ICD-10 Finland

Other secondary gonarthrosis

5.9

31.0

155

D05AX

ATC

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3000475) Leukocytes [#/volume] in Synovial fluid

510

804

7.09

314.88

2.0

1.6

e6/l

7238.4

12075.9

2.09

407

577

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1579

6188

3.50

311.78

1.4

1.3

iu/ml

65.7

31.2

0.71

415

1993

(3019069) Monocytes/100 leukocytes in Blood

3323

16167

6.25

307.65

14.0

6.3

8.8

8.6

6.24

3257

15188

(3006504) Eosinophils/100 leukocytes in Blood

3320

16074

6.28

307.65

13.5

6.0

2.9

0.73

3252

15014

(3002030) Lymphocytes/100 leukocytes in Blood

3337

16636

6.08

307.65

13.8

6.0

29.7

28.3

13.80

3273

15545

(3025159) Blasts/100 leukocytes in Blood

1033

2542

5.08

307.65

5.5

4.2

0.0

0.3

0.99

170

615

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

858

1046

10.07

307.65

1.6

iu/ml

0.3

0.04

169

210

(3013115) Eosinophils [#/volume] in Blood

3640

17861

9.30

307.65

13.2

6.1

e9/l

0.2

0.28

3491

15734

(3006315) Basophils [#/volume] in Blood

3612

17240

9.31

307.65

12.9

5.9

e9/l

0.0

8.03

3453

14944

(3021440) Promyelocytes/100 leukocytes in Blood

1057

2712

4.88

307.65

5.5

4.2

0.0

0.2

1.92

195

738

(3018010) Neutrophils/100 leukocytes in Blood

3321

16418

6.07

307.65

13.3

5.9

56.0

56.9

5.96

3256

15406

(3037522) Nuclear Ab [Titer] in Serum

1456

4902

4.03

307.65

1.4

1.3

titre

384.1

549.9

3.48

287

1008

(40760892) CBC W Ordered Manual Differential panel - Blood

1905

7822

3.65

307.65

8.1

4.4

—

(3019198) Lymphocytes [#/volume] in Blood

3611

17681

8.90

307.65

13.1

5.9

e9/l

2.0

1.9

0.86

3480

15646

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1641

5869

3.97

307.65

1.4

1.3

u/ml

8.1

12.2

1.65

646

2395

(42870588) Differential panel, method unspecified - Blood

2730

11498

5.00

307.65

11.2

5.9

—

(3022096) Basophils/100 leukocytes in Blood

3287

15592

6.28

307.65

13.5

6.0

0.8

0.7

16.30

3217

14579

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

583

885

7.50

307.65

1.7

1.4

—

(3002179) Metamyelocytes/100 leukocytes in Blood

1001

2593

4.77

307.65

4.8

4.0

0.3

0.6

2.55

152

579

(3013650) Neutrophils [#/volume] in Blood by Automated count

3710

19922

8.97

307.65

15.7

9.2

e9/l

3.9

4.0

5.98

3549

17438

(3017181) Myelocytes/100 leukocytes in Blood

1076

2847

4.75

307.65

5.5

4.2

0.5

0.9

3.33

200

801

(3013707) Erythrocyte sedimentation rate by Westergren method

3857

25641

7.92

307.65

9.7

3.9

mm/h

12.0

11.3

2.69

3770

23909

(3001604) Monocytes [#/volume] in Blood

3602

17171

9.18

307.65

12.8

5.8

e9/l

0.6

2.74

3441

14898

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

3842

26541

6.86

301.51

11.4

7.6

u/l

76.1

77.2

1.05

3782

25097

(3021589) Normoblasts [#/volume] in Blood

2738

15295

3.31

291.64

16.1

9.2

e9/l

0.0

0.89

2520

12507

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

208

23.24

285.56

1.4

2.1

mg/l

8.5

9.3

0.51

157

(3037467) Urinalysis macro (dipstick) panel - Urine

3508

23137

4.29

279.67

6.5

4.1

—

(3021788) Differential panel - Synovial fluid

405

599

7.38

264.16

1.7

1.6

—

(3008898) HLA-B27 [Presence]

574

1255

5.15

249.78

1.1

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

321

386

8.93

249.45

1.9

1.6

49.8

59.0

2.65

205

240

(3021601) Nitrite [Presence] in Urine by Test strip

2782

16544

3.06

248.70

6.8

4.6

estimate

0.0

0.80

724

3077

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

174

25.53

248.21

1.3

1.9

au/ml

238.4

66.2

—

(3009261) Glucose [Presence] in Urine by Test strip

2797

16710

3.06

247.39

5.1

3.4

estimate

0.0

0.27

690

2961

(3023420) DNA double strand Ab [Units/volume] in Serum

306

358

9.15

242.91

1.3

1.5

iu/ml

55.7

25.4

—

(3035350) Ketones [Presence] in Urine by Test strip

2763

16520

3.00

241.61

5.0

3.4

estimate

0.0

1.08

677

3000

(3026493) Urate [Moles/volume] in Serum or Plasma

1812

9159

2.73

210.39

2.7

2.6

umol/l

3788.9

4156.3

0.16

1631

8062

(3021879) Hepatitis B virus core Ab [Presence] in Serum

815

2652

3.58

206.02

1.2

1.4

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

262

310

8.95

205.75

1.9

1.4

39.1

30.1

2.31

160

190

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

357

652

5.90

188.24

3.1

3.9

55.8

57.7

2.02

357

652

(3017143) Hepatitis C virus Ab [Presence] in Serum

1023

4034

3.04

186.56

1.3

1.6

—

(3015736) pH of Urine

2190

12779

2.51

180.69

4.5

3.2

—

5.7

—

(3044941) Cell count panel - Synovial fluid

317

556

6.09

174.09

1.6

1.4

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1112

4913

2.72

161.16

1.4

1.6

—

(3018095) Leukocytes [#/volume] in Urine

1984

11642

2.35

153.84

4.0

3.6

e6/l

74.1

92.6

0.47

1408

8192

(40758558) Short blood count panel - Blood

1607

8819

2.34

143.11

10.8

6.8

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2210

13923

2.25

140.32

2.5

2.2

nmol/l

76.5

76.9

0.29

2079

12689

(3010144) Erythrocytes [#/volume] in Synovial fluid

205

312

6.86

128.99

1.8

1.3

e6/l

24312.6

73641.0

0.74

144

217

(3034891) Synovial lining cells/100 cells in Synovial fluid

142

155

9.45

118.20

1.8

1.4

4.0

4.1

0.02

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1999

12857

2.07

111.40

5.6

3.5

—

(3029937) Albumin [Presence] in Urine by Test strip

1516

8846

2.12

109.26

5.6

3.8

estimate

0.0

1.49

715

2971

(3011397) Hemoglobin [Presence] in Urine by Test strip

1374

7741

2.16

108.31

4.6

3.4

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

4028

35012

5.74

106.33

22.5

13.3

mg/l

16.1

22.9

51.69

3648

27456

(3041096) Erythrocytes [Presence] in Urine by Automated

1505

9068

2.03

96.82

4.8

3.1

—

(3002582) Erythrocytes [#/volume] in Urine

1585

9929

1.96

89.59

3.3

3.2

e6/l

35.8

102.9

3.10

1325

7569

(3000850) Epithelial cells [#/volume] in Urine

1202

6849

2.06

88.73

2.7

2.6

e6/l

4.8

5.5

0.97

1082

5980

(3030467) Casts [#/volume] in Urine by Automated count

1466

9127

1.94

82.88

3.3

3.1

e6/l

0.3

0.4

0.46

1204

6815

(3015171) Extractable nuclear Ab [Units/volume] in Serum

393

1391

3.02

82.68

1.2

u/ml

0.5

1.4

1.26

118

(46235355) HIV 1 and 2 tests - Meaningful Use set

1065

5964

2.06

81.34

1.5

1.8

—

(3024263) Appearance of Synovial fluid

124

189

6.73

77.73

2.6

1.5

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

106

9.05

76.22

2.5

2.7

au/ml

163.6

106.1

0.40

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

100

9.18

73.80

1.4

1.6

ug/l

9.3

8.7

0.66

100

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

246

699

3.68

73.67

1.1

1.2

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

116

8.27

70.95

2.6

3.1

mg/l

7.2

7.8

0.33

(3002385) Erythrocyte distribution width [Ratio]

3471

29328

2.11

68.91

26.8

16.1

13.9

13.6

25.93

3456

28712

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

313

1085

3.04

67.99

1.2

1.3

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

318

1113

3.01

67.91

1.7

1.8

—

(36304419) Bacteria [Presence] in Urine

1387

8942

1.83

67.13

3.2

3.0

—

(3000494) Fungus identified in Specimen by Culture

788

4210

2.08

66.84

1.5

—

(3026782) Osmolality of Urine

1047

6321

1.88

61.63

3.0

2.7

mosm/kgh2o

565.4

546.6

1.88

939

5386

(3042936) Bacteria identified in Isolate by Culture

837

4789

1.94

57.57

2.2

2.1

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

3769

33444

2.35

57.48

19.1

12.2

ml/min/173m2

86.3

83.3

16.82

3421

27715

(40768443) Skin Pathology biopsy report

352

1481

2.50

52.32

1.2

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2131

16356

1.62

49.53

5.8

6.9

mmol/l

1.2

0.15

1806

13920

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4051

37704

3.84

47.87

23.8

10.1

u/l

30.0

27.4

16.85

4020

36530

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

903

5612

1.78

46.52

2.6

2.7

e6/l

1.0

1.2

0.53

604

3160

(3019150) Specific gravity of Urine by Refractometry

1079

7174

1.68

43.09

5.7

3.8

kg/l

1.0

1.20

157

1022

(3000330) Specific gravity of Urine by Test strip

342

1558

2.30

42.34

4.3

3.1

—

(3007853) Bacteria identified in Skin by Aerobe culture

677

3994

1.83

40.97

2.0

1.8

—

(1761482) Bacteria [#/volume] in Urine by Culture

201

720

2.88

40.93

5.3

3.9

—

(3009871) Measles virus Ab [Titer] in Serum

118

6.02

39.77

1.7

—

(3005719) IgG [Mass/volume] in Serum or Plasma

500

2705

1.96

39.41

2.0

2.8

g/l

10.7

10.5

0.28

461

2474

(3017732) Neutrophils [#/volume] in Blood

463

2446

2.00

39.05

3.7

2.9

e9/l

3.9

4.0

0.68

374

1969

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2209

17685

1.53

38.59

5.2

6.4

umol/l

10.6

11.2

1.51

2108

16835

(3024561) Albumin [Mass/volume] in Serum or Plasma

1858

14370

1.53

37.87

4.4

5.0

g/l

35.7

35.8

0.30

1744

13437

(3023368) Bacteria identified in Blood by Culture

1222

8640

1.59

37.07

4.5

4.4

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

116

5.85

37.05

1.6

1.2

46.7

54.0

0.73

(3007164) IgA [Mass/volume] in Serum or Plasma

994

6780

1.61

34.68

1.5

g/l

2.6

2.4

1.58

636

4260

(3031040) Bacteria [#/volume] in Urine by Automated count

2597

21793

1.51

34.37

4.7

4.1

e6/l

1775.0

1722.4

0.02

281

(3028026) IgM [Mass/volume] in Serum or Plasma

401

2103

2.00

34.36

1.6

1.9

g/l

1.2

1.3

0.59

366

1932

(3045424) Erythrocytes [Presence] in Urine

168

604

2.86

33.98

1.5

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

332

1632

2.12

33.89

2.5

2.7

e6/l

0.2

0.3

0.51

325

1590

(3018418) pH of Serum or Plasma

1326

9714

1.54

33.68

3.5

4.2

7.4

0.47

286

1847

(3022948) Iron [Moles/volume] in Serum or Plasma

790

5129

1.67

33.41

2.4

2.5

umol/l

13.0

13.6

1.40

743

4771

(3048689) Calprotectin [Mass/mass] in Stool

675

4207

1.72

33.25

2.4

2.3

ug/g

143.0

134.2

0.22

557

3367

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

6.28

32.11

1.6

1.3

45.2

28.7

2.08

(3045414) Leukocytes [Presence] in Urine

315

1556

2.11

31.71

1.7

1.9

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

227

987

2.37

31.16

1.7

1.8

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

114

346

3.36

30.82

2.9

2.5

—

(40761536) Microorganisms panel - Urine sediment

492

2861

1.82

30.64

4.3

3.7

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1116

8015

1.54

30.45

2.4

2.2

mg/l

3.1

2.9

1.63

988

6859

(40761535) Cells panel - Urine sediment

472

2720

1.83

30.26

5.0

3.3

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

685

4402

1.67

29.81

2.4

2.6

22.2

23.6

1.67

606

3797

(3004789) Transferrin [Mass/volume] in Serum or Plasma

726

4742

1.64

29.63

2.4

2.5

g/l

2.4

2.3

2.49

677

4413

(3004809) Band form neutrophils/100 leukocytes in Blood

145

520

2.85

29.48

2.7

3.4

0.9

1.5

1.43

110

412

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

226

1021

2.28

28.39

1.2

u/ml

5.0

44.8

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

453

2642

1.80

27.81

2.8

4.1

mmol/l

1.2

0.16

414

2314

(3007566) Smooth muscle Ab [Titer] in Serum

223

1016

2.26

27.45

1.2

titre

100.0

146.5

0.32

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

213

952

2.30

27.44

1.2

1.3

u/ml

13.4

8.1

0.39

157

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1838

14848

1.43

26.61

5.1

6.2

mmol/l

1.2

0.12

1720

13546

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

894

6287

1.54

26.27

1.6

1.5

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

208

942

2.27

25.97

1.2

u/ml

3.4

6.1

0.32

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

176

749

2.41

25.35

1.2

u/ml

1.2

3.7

0.99

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

763

5228

1.56

25.08

2.9

e6/l

2.8

2.5

0.51

467

2792

(3034770) Mitochondria Ab [Titer] in Serum

214

1009

2.18

24.22

1.2

titre

522.0

1218.3

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1483

11794

1.40

22.26

3.5

3.3

u/l

33.0

35.4

0.76

1403

11221

(3039162) Centromere protein B Ab [Units/volume] in Serum

118

445

2.70

21.87

1.2

1.3

u/ml

99.8

46.6

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1024

7644

1.45

21.83

1.3

1.2

u/ml

1.5

1.8

0.29

289

2066

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

213

1048

2.09

21.61

1.5

1.6

g/l

0.2

0.42

204

991

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1304

10225

1.40

20.96

2.1

2.2

u/l

150.6

226.6

3.90

1226

9637

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

167

757

2.26

20.84

1.2

u/ml

38.9

47.6

0.22

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1625

13224

1.38

20.83

2.1

1.9

pmol/l

92.5

96.8

3.36

944

6927

(3027945) Reticulocytes/100 erythrocytes in Blood

525

3445

1.60

20.47

2.5

2.6

1.8

0.61

472

3057

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

216

1095

2.03

20.22

1.6

g/l

1.2

1.65

209

1036

(3026008) Bacteria identified in Urine by Culture

1172

9158

1.39

18.80

3.1

2.9

—

(3013512) EKG study

1213

9535

1.38

18.77

4.2

3.6

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1015

7743

1.41

18.74

1.7

1.8

mg/l

1.1

0.24

805

5906

(3013826) Glucose [Moles/volume] in Serum or Plasma

2283

19790

1.34

18.56

4.5

4.8

mmol/l

6.7

0.36

2154

18552

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1120

8708

1.39

18.45

2.9

ng/l

1315.9

1136.0

0.67

948

7359

(3019550) Sodium [Moles/volume] in Serum or Plasma

3801

35963

1.66

18.42

17.1

15.0

mmol/l

139.6

139.7

3.25

3721

35130

(3023103) Potassium [Moles/volume] in Serum or Plasma

3812

36094

1.67

18.42

17.2

15.1

mmol/l

3.9

4.0

3.82

3729

35192

(3007461) Platelets [#/volume] in Blood

4066

39314

2.52

18.35

34.7

19.5

e9/l

258.7

252.7

7.21

4037

38426

(3036670) Protein [Mass/volume] in Synovial fluid

4.70

17.96

1.2

g/l

36.8

38.0

0.26

(3024731) MCV [Entitic volume]

4066

39335

2.49

17.95

34.5

19.4

92.2

90.9

63.39

4050

38860

(3035941) MCH [Entitic mass]

4066

39337

2.49

17.91

34.4

19.4

30.6

30.3

25.60

4050

38859

(3026361) Erythrocytes [#/volume] in Blood

4066

39342

2.48

17.81

34.6

19.5

e12/l

4.5

14.10

4030

38361

(3010813) Leukocytes [#/volume] in Blood

4066

39349

2.47

17.68

34.7

19.5

e9/l

6.9

6.6

11.54

4033

38365

(3000963) Hemoglobin [Mass/volume] in Blood

4066

39351

2.47

17.64

34.8

19.6

g/l

136.4

136.9

1.49

4048

38870

(3021960) Folate [Moles/volume] in Serum or Plasma

951

7240

1.41

17.60

1.7

1.5

nmol/l

20.6

20.5

0.06

839

6252

(3026389) Candida sp identified in Specimen by Organism specific culture

108

436

2.52

17.51

1.3

—

(3032080) INR in Blood by Coagulation assay

1591

13170

1.34

17.28

8.7

8.4

inr

1.2

1.14

549

3855

(3001729) Color of Synovial fluid

7.54

16.96

2.1

1.2

—

(3025941) Bacteria identified in Stool by Culture

325

1983

1.69

16.80

1.3

1.2

—

(3019309) Folate [Moles/volume] in Red Blood Cells

757

5588

1.43

16.55

1.8

1.7

nmol/l

1160.0

1167.8

0.08

607

4289

(3023520) Reticulocytes [#/volume] in Blood

394

2537

1.61

16.49

2.2

2.6

e9/l

73.6

70.7

0.73

295

1898

(3015377) Calcium [Moles/volume] in Serum or Plasma

1373

11186

1.34

16.39

2.6

3.4

mmol/l

2.3

2.4

1.03

1233

9909

(3017354) Segmented neutrophils/100 leukocytes in Blood

304

2.77

16.36

3.0

3.6

58.1

57.3

0.10

201

(3052851) Hemolysis interference index of Serum or Plasma

189

989

1.95

16.20

2.4

3.1

—

(3020630) Protein [Mass/volume] in Serum or Plasma

399

2590

1.60

16.14

2.0

2.8

g/l

67.7

66.7

1.97

367

2382

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1738

14669

1.32

16.13

3.1

2.8

ug/l

138.6

129.0

0.90

1622

13696

(40761511) CBC panel - Blood by Automated count

3854

36801

1.64

15.40

18.5

12.3

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

3461

32354

1.41

15.14

6.3

5.4

mmol/mol

39.8

39.5

1.43

3244

30221

(3004588) Protein electrophoresis panel - Serum or Plasma

337

2140

1.63

14.90

1.9

2.5

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

472

3238

1.52

14.89

2.0

2.2

nmol/l

343.6

369.5

1.84

437

2985

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1310

10715

1.32

14.88

2.5

2.6

u/l

53.5

58.5

5.26

1215

9943

(3002032) Base excess in Venous blood by calculation

431

2904

1.54

14.78

3.8

mmol/l

2.3

1.9

1.53

350

2380

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1492

12490

1.30

14.14

3.9

3.4

ng/l

100.1

45.4

0.67

1007

8087

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

887

6891

1.37

14.10

1.8

1.6

pmol/l

92066078.7

33115972.3

0.66

731

5816

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

516

3645

1.47

14.08

3.1

4.5

u/l

245.1

244.3

0.03

487

3456

(3021447) Carbon dioxide [Partial pressure] in Venous blood

427

2910

1.52

13.87

3.8

kpa

5.9

5.8

0.09

419

2830

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2936

26895

1.31

13.64

4.2

4.0

pmol/l

14.7

0.01

2716

24711

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

246

1478

1.71

13.47

2.8

2.7

0.7

0.92

239

1420

(3024354) Oxygen [Partial pressure] in Venous blood

356

2350

1.56

13.36

3.6

3.0

kpa

4.5

4.7

0.78

349

2277

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

3417

32061

1.37

13.03

5.0

4.7

mu/l

1.8

2.2

2.46

3176

29641

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

271

2.61

12.47

1.2

1.1

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

216

1280

1.73

12.44

2.2

2.0

ug/l

1.9

0.06

192

1146

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

234

1421

1.69

12.33

1.5

1.7

g/l

1.6

0.61

195

1224

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

275

2.57

12.12

1.2

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

271

2.57

11.96

1.2

1.1

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

371

2534

1.51

11.89

2.3

2.4

au/ml

23.8

21.4

0.08

153

(3036071) Salmonella sp Ab [Titer] in Serum

135

3.28

11.88

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

272

2.56

11.87

1.2

1.1

—

(40768797) Stomach Pathology biopsy report

644

4880

1.38

11.76

1.3

1.2

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

168

3.00

11.62

1.1

iu/ml

2.8

3.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

275

2.53

11.62

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

275

2.53

11.62

1.2

1.1

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

110

541

2.06

11.31

1.2

—

(3022621) pH of Urine by Test strip

316

2108

1.54

11.31

3.3

2.8

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

353

2.32

11.24

1.2

u/l

58.8

55.7

0.26

245

(3035611) Eosinophils/100 leukocytes in Synovial fluid

6.45

11.08

2.5

1.2

0.3

0.4

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

340

2318

1.51

10.99

1.3

au/ml

55.1

48.5

—

109

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

306

2.38

10.60

1.2

1.3

titre

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

3697

35376

1.40

10.53

4.9

4.3

mmol/l

4.7

3.37

3473

33175

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

340

2340

1.49

10.50

1.6

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

117

605

1.96

10.50

1.4

1.7

g/l

0.7

0.8

0.57

457

(3020682) Albumin/Creatinine [Ratio] in Urine

1230

10347

1.27

10.45

4.0

mg/mmol

12.0

9.1

0.90

810

6554

(3020961) Endomysium IgA Ab [Titer] in Serum

251

1631

1.57

10.10

1.1

titre

23.0

173.0

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

660

5133

1.34

10.09

1.8

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

201

1241

1.65

9.98

1.8

2.4

g/l

4.2

3.8

2.09

134

910

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

201

1242

1.65

9.95

1.8

2.4

g/l

7.7

7.3

2.00

141

952

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

201

1242

1.65

9.95

1.8

2.4

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

3567

33995

1.35

9.91

4.4

3.9

mmol/l

1.4

1.3

10.10

3318

31548

(3022145) Colonoscopy Study observation

522

3933

1.37

9.78

1.3

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

462

3429

1.39

9.48

3.2

3.3

—

(3004616) Nuclear Ab [Presence] in Serum

449

2.05

9.35

1.3

1.2

—

(3022217) INR in Platelet poor plasma by Coagulation assay

528

4019

1.36

9.26

20.7

22.3

inr

1.2

1.3

0.47

592

(21494755) Public health laboratory ask at order entry panel

280

3985

0.68

8.70

1.3

1.4

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

3663

35171

1.35

8.69

4.8

4.3

mmol/l

1.4

1.5

5.03

3421

32827

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

728

5858

1.29

8.61

2.5

3.0

mmol/l

2.4

0.28

643

5151

(3012095) Magnesium [Moles/volume] in Serum or Plasma

695

5560

1.30

8.59

2.6

3.6

mmol/l

0.8

1.63

658

5229

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

212

2.47

8.45

1.4

1.6

u/l

8.8

6.1

0.57

110

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

164

2.64

8.02

1.1

—

(3021901) Oxygen saturation in Capillary blood

104

568

1.85

8.01

2.7

2.8

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

136

809

1.70

7.85

3.2

3.1

mmol/l

25.0

24.8

0.16

113

700

(3014051) Protein [Presence] in Urine by Test strip

130

765

1.72

7.80

2.1

2.2

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

428

3239

1.36

7.76

2.3

g/l

0.2

0.31

401

3038

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

126

737

1.73

7.73

1.3

2.1

nmol/l

0.9

0.8

0.53

109

625

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2509

23197

1.21

7.73

3.0

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

115

658

1.77

7.62

1.6

1.7

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

200

1327

1.53

7.41

1.6

1.7

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

150

931

1.63

7.38

2.2

3.8

ratio

2.4

2.1

—

(3044889) 12 lead EKG panel

2647

24655

1.20

7.30

3.6

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

3556

34156

1.28

7.25

4.6

4.4

mmol/l

6.0

5.9

6.25

3281

31514

(3034860) Kappa light chains.free [Mass/volume] in Serum

153

959

1.62

7.25

2.2

3.9

mg/l

84.5

58.8

0.32

115

779

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

180

1173

1.56

7.23

1.8

2.4

g/l

3.3

3.1

1.00

135

929

(3005322) IgE [Units/volume] in Serum or Plasma

316

2303

1.40

7.22

1.3

u/ml

214.6

215.8

0.01

294

2132

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

153

962

1.61

7.16

2.2

3.9

mg/l

81.3

65.1

0.16

116

783

(3009508) Creatinine [Moles/volume] in Urine

1220

10599

1.21

7.15

3.0

3.2

mmol/l

7.9

7.8

0.08

1014

9017

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

205

2.36

7.11

1.6

1.5

u/ml

20.7

20.9

0.01

(3012516) Albumin [Mass/volume] in Urine

1142

9866

1.22

7.07

3.1

3.3

mg/l

441.4

382.2

0.16

728

6225

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

176

1149

1.56

7.03

1.8

2.4

g/l

10.7

10.2

0.67

152

987

(3009542) Hematocrit [Volume Fraction] of Blood

3410

32624

1.25

6.97

24.2

14.1

39.4

40.3

5.35

2387

24536

(3028626) Oxygen [Partial pressure] in Capillary blood

115

677

1.72

6.93

2.8

kpa

8.0

8.1

0.44

106

618

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

3713

35910

1.32

6.86

5.2

4.7

mmol/l

2.8

2.73

3457

33486

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

165

1070

1.56

6.80

1.9

2.5

g/l

1.0

0.9

0.05

141

942

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

224

1560

1.46

6.59

1.6

1.9

u/l

40.2

39.2

0.31

210

1403

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

163

2.47

6.58

2.1

3.2

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

506

4016

1.30

6.57

2.7

2.8

umol/l

9.1

8.0

0.32

431

3505

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

118

715

1.67

6.43

1.5

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

191

1297

1.50

6.38

3.7

5.9

1.5

1.7

2.08

181

1208

(3008757) Leukocyte morphology finding [Identifier] in Blood

350

1.96

6.34

2.3

4.0

—

(3013637) Mi-2 Ab [Presence] in Serum

3.04

6.33

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

3.04

6.33

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

3.04

6.33

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

3.04

6.33

1.1

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

374

2865

1.34

6.27

3.3

2.5

ml/min/173m2

67.5

67.9

0.07

155

1073

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

518

1.77

6.21

1.1

—

(40760888) Immunoglobulin light chains.free panel - Serum

117

715

1.65

6.18

2.1

4.1

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

176

1190

1.50

6.03

1.5

1.6

titre

378.0

329.6

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

146

950

1.56

5.97

1.8

2.4

g/l

0.0

1.04

133

882

(3003327) Ova and parasites identified in Stool by Light microscopy

171

1154

1.50

5.92

1.8

1.7

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

109

662

1.66

5.91

1.1

1.3

—

265.3

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

276

2036

1.38

5.91

3.3

3.5

kpa

5.2

0.02

251

1887

(3047007) Chlamydophila sp Ab [Presence] in Serum

514

1.75

5.81

1.2

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

103

621

1.68

5.76

1.1

—

(4062490)

391

1.86

5.75

1.4

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

513

4147

1.27

5.75

6.3

7.4

mmol/l

104.1

104.4

1.10

504

4062

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

174

2.31

5.75

1.4

1.3

titre

94.0

62.6

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

135

872

1.57

5.72

1.2

1.3

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

388

1.84

5.57

1.3

1.4

g/l

6.6

6.8

0.25

269

(3024139) IgG subclass 3 [Mass/volume] in Serum

388

1.84

5.57

1.3

1.4

g/l

0.4

0.43

269

(3028192) IgG subclass 2 [Mass/volume] in Serum

389

1.84

5.53

1.3

1.4

g/l

3.2

2.9

0.69

271

(1616796) Gas panel - Central venous blood

113

706

1.62

5.51

2.8

3.8

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1076

9428

1.19

5.51

1.8

1.7

mmol/l

1.5

1.4

3.23

898

7973

(3009343) pH of Capillary blood

269

2005

1.37

5.42

3.3

3.5

7.4

0.66

253

(3007930) Methemoglobin/Hemoglobin.total in Blood

185

1292

1.45

5.42

4.1

5.9

0.8

0.9

3.10

176

1205

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

157

1062

1.50

5.40

2.4

2.7

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

219

2.11

5.35

1.2

1.6

u/l

5.0

7.0

1.49

188

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

234

1710

1.39

5.33

2.4

2.3

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1752

16029

1.16

5.18

4.2

4.0

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

439

3532

1.27

5.12

1.7

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

597

1.64

5.06

1.3

1.8

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

1432

0.61

5.01

1.5

1.7

mg/l

3.9

4.0

0.07

1015

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

175

2450

0.70

5.00

1.5

1.4

—

(1617658) Protocol used for examination of sentinel lymph nodes

279

0.25

4.96

1.0

1.1

—

(3033658) Prothrombin time (PT) actual/Normal

1006

8835

1.18

4.94

4.3

4.0

91.7

92.1

0.24

980

8605

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

341

1.83

4.82

1.2

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

109

699

1.57

4.82

2.0

2.2

g/l

130.7

130.3

0.05

505

(40767503) Oxygen content in Capillary blood by calculation

109

700

1.57

4.79

2.3

2.5

16.9

16.4

0.50

348

(3044640) Blood type and Crossmatch panel - Blood

1200

10715

1.17

4.79

2.5

2.4

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

255

1928

1.34

4.72

3.2

3.5

mmol/l

1.9

1.7

0.22

185

1462

(3003458) Phosphate [Moles/volume] in Serum or Plasma

523

4344

1.23

4.62

4.9

6.3

mmol/l

1.0

0.48

507

4070

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

566

4745

1.22

4.57

1.7

1.8

1.6

1.5

3.57

481

4226

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2582

24421

1.15

4.55

3.5

3.1

u/l

57.7

48.3

4.64

2419

22991

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

131

889

1.49

4.50

1.9

2.4

g/l

0.0

0.00

119

823

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

405

3279

1.26

4.50

2.9

2.5

u/l

36.7

53.5

0.58

355

2846

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

243

1839

1.34

4.48

1.6

1.5

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

142

980

1.46

4.48

1.8

2.3

g/l

37.5

37.8

0.22

121

860

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

111

728

1.54

4.48

2.5

6.1

iu/ml

172.2

584.4

—

110

(40768793) Breast Pathology biopsy report

777

0.51

4.47

1.3

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

462

1.68

4.47

1.3

1.6

—

(3017569) Oxygen content in Arterial blood

155

2.20

4.45

1.7

2.5

—

(3002619) Bacteria identified in Specimen by Culture

2.93

4.43

1.5

1.1

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

435

3558

1.25

4.42

1.8

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

557

1.61

4.39

1.2

1.4

—

(3009015) Lactate [Moles/volume] in Synovial fluid

3.72

4.36

1.1

1.3

mmol/l

3.5

5.8

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

129

881

1.48

4.31

1.9

2.4

g/l

0.0

0.00

119

822

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

576

1.59

4.29

1.1

iu/ml

33.8

996.3

0.54

137

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

253

1.91

4.29

1.2

1.6

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

635

1.56

4.19

2.1

3.2

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

121

822

1.49

4.16

1.4

1.6

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

148

1049

1.43

4.09

1.2

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

295

3707

0.78

4.08

1.8

—

(40768804) Tissue Pathology biopsy report

1556

14289

1.14

4.07

2.0

—

(44813793)

245

1.89

4.01

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

143

1012

1.43

3.99

1.2

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

144

1021

1.43

3.98

1.2

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

440

1.65

3.94

1.1

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

479

1.62

3.93

1.4

1.5

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

732

6381

1.18

3.85

3.8

3.5

ng/l

363.4

610.1

0.68

524

4727

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

138

979

1.42

3.82

1.4

1.3

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

120

2.26

3.80

2.0

2.1

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

117

806

1.46

3.79

1.4

1.7

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

164

1201

1.38

3.78

1.8

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

629

1.52

3.73

1.1

—

(40768800) Prostate Pathology biopsy report

652

0.52

3.72

1.2

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

251

0.32

3.69

4.8

13.0

nmol/l

604.3

842.1

—

241

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

254

0.31

3.68

5.6

17.4

nmol/l

966.5

1473.9

—

246

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

203

1.93

3.67

1.2

u/l

14.5

22.0

0.86

169

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

465

1.60

3.65

1.5

1.4

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

140

1006

1.41

3.62

1.2

—

(3037756) Immunofixation for Serum or Plasma

642

1.51

3.61

1.4

1.7

—

(3027315) Oxygen [Partial pressure] in Blood

108

742

1.47

3.57

3.5

4.4

kpa

8.5

8.6

0.32

108

731

(3051101) Glucose [Moles/volume] in Cord blood

3.05

3.52

2.4

6.5

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

176

1320

1.35

3.52

2.0

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

101

687

1.48

3.51

4.4

3.5

mg/l

22.9

24.9

0.22

414

(3000570) Elastase.pancreatic [Mass/mass] in Stool

139

1010

1.39

3.40

1.5

1.4

ug/g

277.5

285.7

0.20

572

(3035320) C reactive protein [Mass/volume] in Body fluid

231

1.83

3.37

2.8

2.4

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

154

1140

1.36

3.36

1.9

2.4

ug/l

356.1

581.8

0.63

139

1075

(36660697) Celiac disease serology panel - Serum

335

2750

1.24

3.34

1.2

—

(3042631) Mycobacterium sp identified in Specimen

438

1.59

3.30

2.5

2.7

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

379

3156

1.22

3.30

1.8

1.9

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

155

2.01

3.29

1.2

—

(3013290) Carbon dioxide [Partial pressure] in Blood

106

741

1.44

3.23

3.4

4.3

kpa

5.1

5.0

0.12

106

731

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

282

1.71

3.11

1.2

titre

196.7

177.4

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

232

1842

1.27

3.10

1.7

1.6

—

(3012501) Base excess in Blood by calculation

105

741

1.43

3.06

3.4

4.3

mmol/l

2.4

2.5

0.19

504

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

298

2442

1.24

3.04

3.7

3.9

ng/l

82.2

88.1

0.61

255

2142

(4211845)

153

1.97

3.04

6.3

2.8

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

330

1.64

3.04

1.2

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

2.51

3.03

1.7

2.7

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

323

1.65

3.01

3.2

3.9

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

595

1.47

3.00

1.2

1.1

—

(3000991) Gas panel - Venous blood

328

2720

1.22

3.00

6.9

9.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.35

2.98

1.2

1.1

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

371

1.60

2.97

1.3

1.7

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

257

1.72

2.93

1.6

1.8

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

345

2884

1.21

2.92

6.1

7.6

mmol/l

1.4

1.3

0.23

329

2780

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

213

1.79

2.91

1.2

u/l

69.0

88.3

1.42

183

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

416

3540

1.19

2.91

1.8

1.9

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

328

2732

1.22

2.88

2.2

2.3

ug/l

5.0

8.2

4.57

287

2450

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

528

1.49

2.84

1.5

1.4

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

245

1981

1.25

2.84

6.0

7.8

mmol/l

25.0

24.8

0.35

245

1970

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

130

2.01

2.80

1.1

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

607

1.44

2.73

1.5

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

435

3743

1.18

2.69

6.2

8.1

kpa

5.3

5.1

2.26

422

3578

(3027801) Oxygen [Partial pressure] in Arterial blood

435

3744

1.18

2.69

6.1

8.1

kpa

12.4

12.6

0.24

422

3578

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

710

1.40

2.68

1.8

1.5

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

326

1.60

2.68

1.4

1.6

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

197

1.78

2.67

1.3

1.2

—

(3015183) Erythrocyte sedimentation rate

197

1.78

2.67

1.2

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

161

1.87

2.66

1.1

miu/ml

1231.1

1474.8

0.74

161

(3018677) aPTT in Platelet poor plasma by Coagulation assay

580

5113

1.16

2.64

1.8

2.1

30.1

29.7

1.08

564

4969

(3036603) Volume of Urine

235

1.71

2.64

1.8

1.5

2065.0

1991.2

0.07

(3000093) Morphology [Interpretation] in Blood Narrative

305

1.61

2.61

1.1

1.2

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

253

1.67

2.54

1.7

2.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

220

1783

1.25

2.53

1.4

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

194

1.76

2.50

1.1

—

(3006462) Nitrate [Presence] in Urine

136

1.92

2.50

6.9

2.9

—

(3000012) Reticulocyte production index

165

1.82

2.48

1.5

—

(3011412) CD3 cells [#/volume] in Blood

349

1.55

2.48

1.7

2.4

e9/l

1.2

1.1

0.03

208

(3002621) Streptococcal DNAse B [Units/volume] in Serum

3.47

2.48

1.0

—

(3041672) Baker's yeast Ab [Presence] in Serum

4.38

2.47

1.1

1.0

—

(3003396) Base excess in Arterial blood by calculation

431

3735

1.17

2.47

6.4

8.1

mmol/l

1.2

1.0

0.30

352

2911

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

218

1.70

2.44

1.2

1.6

—

(3005011) Chlamydia sp Ab [Titer] in Serum

2.55

2.44

1.3

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

304

1.59

2.41

1.4

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

304

1.59

2.41

1.4

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

304

1.59

2.41

1.4

1.7

—

(3037121) Protein [Mass/volume] in Urine

144

1117

1.30

2.38

2.6

3.2

g/l

0.3

0.00

476

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

2.12

2.38

1.2

1.1

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

122

929

1.32

2.32

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

137

1061

1.30

2.30

1.2

1.3

miu/ml

158.1

217.0

1.01

496

(3013139) Helicobacter pylori Ag [Presence] in Stool

277

2325

1.21

2.30

1.2

—

(3010421) pH of Blood

116

880

1.33

2.27

3.2

4.2

7.4

0.50

105

731

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.56

2.27

1.2

1.3

—

(3039443) Prostate specific Ag panel - Serum or Plasma

808

0.68

2.22

1.4

1.6

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

475

1.44

2.19

1.1

—

(3016502) Oxygen saturation in Arterial blood

386

3351

1.17

2.18

6.8

8.5

95.5

95.9

0.67

378

3231

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

189

1.70

2.13

1.3

1.6

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

259

1.59

2.11

1.1

1.3

mmol/l

14.0

12.2

0.71

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

267

1.58

2.11

1.6

2.1

11.2

13.4

0.82

113

(4010399)

286

2432

1.19

2.08

1.4

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

2.91

2.07

1.1

—

3.4

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

269

1.57

2.05

1.2

—

(40768441) Liver Pathology biopsy report

277

1.56

2.05

1.3

1.4

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

145

0.34

2.01

4.6

2.3

nmol/l

146.8

155.6

—

124

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

111

1.90

2.00

1.0

1.3

—

(3022313) Gas panel - Capillary blood

179

1463

1.23

1.97

3.5

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

119

1.85

1.96

1.2

1.1

—

(1761868) Lipid panel - Serum or Plasma

1456

13745

1.09

1.96

3.1

2.7

—

(3032773) Endomysium IgG Ab [Titer] in Serum

273

1.54

1.94

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

210

1.62

1.94

1.0

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

2.19

1.94

1.2

1.1

—

(21494815) CD4 cells/100 lymphocytes in Specimen

306

1.51

1.92

1.7

2.2

51.3

43.6

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.57

1.92

1.1

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

188

1.65

1.90

1.3

1.6

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

207

1726

1.21

1.89

7.9

10.5

mmol/l

24.5

24.3

0.60

195

1629

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

448

1.41

1.89

1.3

nmol/l

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

122

1.81

1.83

1.4

2.0

—

(3051651) Icteric interference index of Serum or Plasma

198

1.62

1.83

3.0

3.4

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

351

1.46

1.82

1.1

—

(3028433) Virus identified in Specimen by Culture

115

1.83

1.82

1.1

1.2

—

(3040151) Glucose [Moles/volume] in Capillary blood

352

1.45

1.80

5.9

5.3

mmol/l

8.2

7.3

0.61

296

(3019420) Tryptase [Mass/volume] in Serum or Plasma

207

1.60

1.79

1.2

1.4

ug/l

7.7

8.5

0.20

181

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

109

1.84

1.77

1.2

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

150

0.40

1.76

1.0

1.5

umol/l

34.8

29.7

—

144

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.09

1.75

1.6

1.3

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

240

1.55

1.75

1.1

1.2

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

653

1.32

1.74

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

653

1.32

1.74

1.3

—

(3013293) Extractable nuclear Ab [Presence] in Serum

2.23

1.73

1.4

1.7

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

439

1.40

1.73

1.5

1.4

pmol/l

348.0

277.1

0.79

348

(3023410) Appearance of Cerebral spinal fluid

356

1.44

1.71

1.5

1.6

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

3.85

1.71

1.2

1.0

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

569

1.34

1.70

1.5

2.8

u/ml

1202.8

1482.2

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

133

1.73

1.69

1.0

1.2

—

(3006270) Folate [Moles/volume] in Blood

275

1.50

1.68

1.1

nmol/l

367.7

379.5

0.14

250

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

3.16

1.66

1.2

1.0

—

(3020650) Glucose [Presence] in Urine

1.86

1.66

1.3

1.4

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

244

1.52

1.65

1.1

1.2

—

(21494890) Protein electrophoresis panel - 24 hour Urine

335

1.44

1.63

1.9

2.2

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

705

1.30

1.62

1.4

—

(3000492) Spirometry study

405

3615

1.13

1.60

1.5

1.4

—

(3020491) Glucose [Moles/volume] in Blood

254

1.50

1.60

2.0

1.8

mmol/l

7.0

6.8

0.18

169

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

190

1.58

1.59

1.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

214

1.55

1.59

1.1

1.2

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

2.70

1.58

2.6

2.3

—

(21494434) Karyotype in Bone marrow

288

1.46

1.57

1.1

1.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

279

2433

1.16

1.56

1.2

iu/ml

117.5

145.8

0.59

107

920

(3044927) Protein electrophoresis panel - Urine

305

1.45

1.56

1.4

1.2

—

(3016018) Differential panel - Cerebral spinal fluid

389

1.39

1.55

1.3

1.4

—

(44806420)

1.93

1.54

2.2

2.5

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

2.43

1.53

1.1

1.0

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

467

1.35

1.53

1.3

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.28

1.53

1.9

1.4

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

2.86

1.50

1.3

1.0

—

(3032057) Clostridioides difficile [Presence] in Stool

2.00

1.48

1.5

2.1

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

360

1.39

1.46

1.3

1.8

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

180

1.56

1.42

1.2

1.1

—

(4034850)

140

1162

1.21

1.41

11.7

8.7

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

181

1.55

1.39

1.3

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

181

1.55

1.39

1.3

1.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

181

1.55

1.39

1.3

1.9

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

398

1.36

1.38

1.1

1.5

—

(3000034) Microalbumin [Mass/volume] in Urine

330

1.40

1.38

2.7

3.1

mg/l

19.9

44.0

1.45

238

(3051611) Lipemic interference index of Serum or Plasma

322

1.40

1.37

2.9

3.2

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

2.61

1.36

1.0

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

2.61

1.36

1.0

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

127

1.66

1.36

1.3

1.5

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

391

1.36

1.3

1.7

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

391

1.36

1.1

—

(3011985) Renin [Units/volume] in Plasma

469

1.33

1.35

1.5

mu/l

86.2

50.9

0.57

422

(21494814) CD8 cells/100 lymphocytes in Specimen

151

1.59

1.34

1.3

2.0

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

151

1.59

1.34

1.4

2.5

umol/l

241.1

126.1

0.26

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

116

951

1.23

1.34

1.1

u/ml

1.3

5.5

2.43

127

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

151

1783

0.84

1.31

2.5

3.3

u/ml

35.4

51.0

0.64

146

1719

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

729

1.25

1.30

1.4

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

137

1.61

1.29

1.1

1.2

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

311

1.39

1.26

1.4

1.5

e6/l

21642.3

86505.3

1.61

184

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

406

1.33

1.25

1.1

1.5

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

1.74

1.24

1.1

u/ml

2.0

1.6

—

(3000285) Sodium [Moles/volume] in Blood

2.04

1.22

1.1

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

2.63

1.21

1.6

1.1

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

120

1000

1.21

1.20

1.9

2.1

u/l

4652.8

4132.9

0.07

386

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.75

1.18

1.1

1.2

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

168

0.53

1.18

2.1

1.9

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

181

1.49

1.18

1.3

1.9

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

239

1.43

1.18

1.9

2.6

e6/l

372.4

548.8

1.73

204

(1002224) Polysomnography panel

194

1689

1.16

1.17

1.0

1.1

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

812

1.22

1.17

2.1

2.4

ug/min

151.0

116.5

0.33

507

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

525

1.28

1.17

1.1

u/ml

2.5

3.3

0.43

252

(3017509) Phencyclidine [Presence] in Urine

0.00

1.16

0.0

1.3

—

(3012441) Differential panel - Pleural fluid

300

1.37

1.14

1.4

1.5

—

(3049717) Cytology report of Urine Cyto stain

140

1191

1.18

1.13

2.4

2.5

—

(3019977) pH of Arterial blood

175

1.49

1.12

4.3

2.8

7.4

0.06

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

2.34

1.12

1.0

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

267

1.39

1.12

1.2

u/ml

0.0

0.6

1.43

118

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

200

1.45

1.12

1.9

2.3

u/ml

1087.7

1071.7

0.02

200

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

385

3511

1.11

1.4

—

(3019225) pH of Specimen

355

3225

1.11

1.10

3.3

4.2

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1153

11001

1.07

1.10

4.2

4.5

ug/l

1.9

2.5

1.96

1023

9953

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

2.38

1.09

1.2

1.1

mmol/l

7.6

8.0

—

(3044242) Glucose [Moles/volume] in Arterial blood

160

1.50

1.09

1.9

2.3

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

1.82

1.09

3.1

2.7

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

112

1.61

1.08

1.1

1.2

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

729

1.23

1.08

1.2

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

105

1.62

1.06

1.1

1.2

96.0

92.2

—

(3004775) Volume in Urine collected for unspecified duration

279

1.37

1.05

2.0

2.2

758.7

632.7

0.79

193

(3050794) Legionella sp Ab [Presence] in Serum

2.12

1.05

1.0

1.1

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

121

1.57

1.05

2.0

2.1

27.1

29.7

0.39

114

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

687

1.23

1.04

1.2

u/ml

346.3

277.8

0.94

428

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.79

1.04

1.2

1.3

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

111

934

1.19

1.04

2.7

3.0

mg/l

1.5

0.01

873

(3008152) Bicarbonate [Moles/volume] in Arterial blood

229

2039

1.13

1.02

7.0

7.5

mmol/l

25.0

24.5

1.33

216

1900

(3006245) CD3-CD19+ cells/100 cells in Blood

122

1.56

1.02

2.0

2.2

9.5

8.7

0.17

114

(3038177) Helicobacter pylori Ab [Presence] in Serum

608

1.24

1.02

1.2

—

(3014007) Fractional oxyhemoglobin in Arterial blood

235

2098

1.13

1.01

8.4

10.0

94.0

0.00

235

2091

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.77

1.00

1.2

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.88

1.00

1.0

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

131

1.53

0.99

3.3

4.3

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

343

3132

1.10

0.99

7.1

9.0

g/l

123.1

122.6

0.16

335

3016

(3045788) Cell count panel - Pleural fluid

283

1.35

0.98

1.5

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

2.18

0.98

1.2

—

1.1

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

2.18

0.98

4.8

3.2

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

0.00

0.97

0.0

1.1

—

(3002256) Pathology report gross observation

485

4505

1.09

0.97

1.3

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

0.96

0.0

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

433

0.74

0.95

1.1

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

103

870

1.19

0.95

1.8

1.9

pmol/l

196.3

204.5

0.39

817

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

278

2519

1.11

0.94

3.1

2.8

ng/l

204.6

167.0

0.56

240

2283

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

166

1.45

0.94

1.6

1.7

—

(3023419) Bacteria identified in Sputum by Culture

426

1.27

0.94

1.6

2.7

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

108

1266

0.85

0.93

1.9

—

(3050129) First trimester maternal screen panel - Serum or Plasma

711

0.80

0.92

1.5

1.4

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

383

1.28

0.92

1.7

1.5

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

350

0.71

0.92

4.7

4.9

u/ml

35.7

77.8

1.02

(3011288) Drugs identified in Urine by Screen method

101

855

1.19

0.91

1.8

3.2

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

110

1.55

0.90

1.1

1.2

—

(3022689) Creatine [Moles/volume] in Urine

110

1.55

0.90

1.1

1.5

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

143

1.47

0.89

1.2

2.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

143

1.47

0.89

1.2

2.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.69

0.88

1.2

1.5

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

242

0.66

0.88

6.5

6.4

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.86

0.87

1.0

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

144

1.46

0.87

1.2

2.1

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

311

0.71

0.86

1.1

1.4

ug/l

3.0

3.9

0.32

259

(3023199) Leukocytes [#/volume] in Pleural fluid

352

1.28

0.85

1.5

e6/l

3074.1

2286.8

0.23

259

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

137

1.46

0.84

1.1

1.0

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

173

1539

1.13

0.83

3.2

4.1

mmol/l

24.4

24.2

0.22

155

1389

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

590

0.79

0.83

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

589

0.80

0.82

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

589

0.80

0.82

1.4

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

319

0.72

0.82

2.7

2.6

—

(4035726)

283

3087

0.91

0.81

1.3

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

588

0.80

0.81

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

487

0.78

0.80

1.4

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.00

0.79

0.0

1.5

—

351.1

—

(3022475) Manganese [Moles/volume] in Blood

0.00

0.79

0.0

1.5

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.78

0.0

1.1

—

(3005033) Fetal Nuchal fold Thickness US

485

0.78

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

402

1.25

0.78

1.1

1.5

—

(3020891) Body temperature

148

1311

1.13

0.77

5.1

4.7

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

0.00

0.77

0.0

7.6

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

190

1710

1.12

0.77

1.4

1.3

iu/l

31.1

30.6

0.08

169

1477

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.76

0.0

1.1

—

(3029075) Extractable nuclear Ab panel - Serum

107

1.50

0.76

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

262

1.30

0.74

1.1

—

(3018572) Chloride [Moles/volume] in Blood

744

0.83

0.74

5.4

8.1

mmol/l

105.1

105.4

0.29

663

(3019060) Gas panel - Arterial blood

233

2126

1.10

0.73

4.6

5.3

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

108

1.48

0.73

1.1

93.8

91.6

—

(3039000) Anion gap in Blood

743

0.83

0.73

5.4

8.1

mmol/l

11.3

11.4

0.03

662

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

662

1.18

0.73

1.3

1.4

u/ml

111.7

115.8

0.14

127

(3027923) C peptide [Moles/volume] in Serum or Plasma

193

1.35

0.73

1.7

1.4

nmol/l

1.4

1.2

0.32

151

(3023183) Ammonium ion [Moles/volume] in Plasma

755

1.17

0.72

3.5

3.1

umol/l

35.8

37.1

0.20

652

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

737

1.17

0.72

1.3

1.4

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.67

0.72

1.1

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.67

0.72

1.1

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.67

0.72

1.1

1.2

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

812

1.16

0.71

1.3

1.4

e6/l

27.0

25.3

0.04

625

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

151

1.39

0.71

2.4

1.5

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

151

1.39

0.71

1.0

3.1

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

151

1.39

0.71

2.4

1.5

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

1.58

0.71

1.0

1.1

—

5.7

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

813

1.16

0.70

1.5

e6/l

1164.2

1286.9

0.06

663

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

1.92

0.70

1.0

1.3

—

40.6

—

(3003181) Sodium [Moles/volume] in Urine

536

1.20

0.70

1.3

mmol/l

67.1

63.5

0.25

431

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.53

0.68

1.1

—

(3048879) Bone marrow aspiration report

1.53

0.68

1.2

2.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

907

0.86

0.67

1.3

1.2

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

111

1.44

0.65

1.3

1.5

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.54

0.65

1.6

1.3

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

394

1.22

0.65

1.1

1.5

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

495

1.19

0.65

2.6

3.2

nmol/l

0.9

0.8

0.28

375

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

671

1.17

0.64

1.8

1.7

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

558

0.82

0.64

1.1

u/ml

0.3

1.9

—

132

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.72

0.64

1.0

1.2

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

325

0.77

0.62

1.2

1.4

pmol/l

78.6

156.6

0.41

107

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

252

1.27

0.62

1.5

2.1

u/field

2.9

2.0

0.37

116

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

632

0.84

0.62

1.4

1.5

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

614

6432

0.95

0.62

2.8

ug/l

0.6

0.7

7.85

379

4025

(3036489) Thrombin time

149

1344

1.11

0.62

1.8

2.0

23.0

21.5

0.65

125

1169

(3001019) Free T4 and TSH panel - Serum or Plasma

195

2129

0.91

0.61

1.8

1.7

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

141

1268

1.12

0.61

3.4

3.7

mmol/l

24.7

24.9

0.65

125

1185

(3005988) Vibrio sp identified in Specimen by Organism specific culture

397

1.21

0.61

1.1

1.5

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

521

5478

0.94

0.60

1.4

1.5

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.60

0.0

5.0

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

148

1.35

0.59

3.6

2.8

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

0.00

0.59

0.0

2.2

—

2.0

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

556

1.17

0.59

1.5

1.7

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

201

1847

1.09

0.58

1.7

1.9

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

0.00

0.58

0.0

2.0

—

3.3

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

246

1.26

0.58

1.0

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

613

1.16

0.58

1.5

1.7

—

(40768446) Kidney Pathology biopsy report

150

0.67

0.58

1.5

1.6

—

(3037556) Urate [Mass/volume] in Serum or Plasma

106

1.42

0.57

1.3

1.4

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

408

0.81

0.56

1.1

u/ml

0.7

0.3

—

(4281824)

375

0.80

0.56

1.2

1.1

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

229

1.27

0.56

1.2

1.1

ratio

1.1

1.0

0.37

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.67

0.56

2.3

2.1

—

(3044290) Cell count panel - Cerebral spinal fluid

738

1.14

0.55

1.3

1.4

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

124

0.64

0.54

1.8

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

151

1.33

0.53

1.2

2.0

ug/l

363.8

20.8

0.47

134

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.49

0.53

1.0

1.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.54

0.53

2.3

2.1

—

(3012898) Urea [Moles/volume] in Urine

1.54

0.53

1.5

1.3

mmol/l

148.6

170.4

—

(3014271) Vancomycin [Susceptibility]

134

1.34

0.53

3.4

2.8

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

159

1455

1.10

0.52

1.6

1.8

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

396

1.19

0.52

1.1

1.5

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

501

0.84

0.52

1.5

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

533

0.84

0.52

5.8

2.6

13.3

13.2

0.29

528

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.50

0.51

1.0

1.2

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

103

923

1.12

0.51

1.3

mg/l

486.8

529.0

0.49

874

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

242

1.24

0.50

1.1

1.0

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

236

0.76

0.50

1.4

1.5

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

325

1.20

0.49

1.2

1.4

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

243

1.24

0.49

1.1

1.0

—

(44790049)

399

1.18

0.49

1.7

1.5

—

(44790048)

399

1.18

0.49

1.7

1.5

—

(44806118)

399

1.18

0.49

1.7

1.5

—

(44790047)

399

1.18

0.49

1.7

1.5

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.56

0.49

24.0

9.8

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

115

1041

1.11

0.48

2.2

2.5

g/l

3.8

3.6

0.71

107

986

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.52

0.48

1.1

1.0

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

453

0.84

0.48

1.1

u/ml

1.3

4.1

—

173

(3021387) Prolactin [Units/volume] in Serum or Plasma

131

1195

1.10

0.48

1.7

1.6

mu/l

252.0

300.1

2.11

118

1084

(44806071)

1.49

0.47

1.0

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

137

1.32

0.47

1.3

1.2

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.41

0.46

1.1

1.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1097

0.90

0.46

1.6

1.5

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

0.59

0.45

1.0

1.3

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

237

1.23

0.45

1.2

—

(3004451) EKG impression Narrative

165

1.27

0.45

1.1

1.3

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

394

1.17

0.44

1.0

1.1

—

72.8

—

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

220

0.77

0.44

7.6

11.5

mmol/l

0.6

0.01

198

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

885

1.11

0.44

1.6

1.9

iu/l

3.3

4.9

1.88

324

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

1.61

0.43

1.2

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

240

0.79

0.42

1.2

1.1

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.56

0.42

1.4

1.9

—

(3000060) B lymphocytes [#/volume] in Blood

1.38

0.42

1.8

2.1

e6/l

118.6

163.0

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

0.64

0.42

1.0

1.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

217

0.78

0.41

1.0

1.1

u/l

0.9

1.1

—

112

(3024928) Oxygen saturation in Venous blood

728

1.11

0.41

2.5

3.0

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

391

0.84

0.41

1.7

1.5

—

(3013762) Body weight Measured

0.00

0.40

0.0

1.2

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

0.40

0.0

5.8

—

401.2

—

(3016750) Collection duration of Urine

213

1.22

0.40

1.8

2.1

min

524.7

488.5

0.76

160

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

114

1.32

0.40

1.9

3.1

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

815

1.11

0.40

1.2

1.3

mmol/l

3.7

3.8

0.49

766

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

1.33

0.40

1.0

1.4

—

(3035880) pH of Pleural fluid

159

1.26

0.40

1.6

1.4

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.40

0.0

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.31

0.39

3.5

1.8

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

102

0.69

0.39

1.3

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

101

0.69

0.39

1.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

389

0.85

0.39

1.2

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

527

0.87

0.38

1.6

1.5

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.39

0.38

1.8

2.8

—

(4024509)

301

0.83

0.37

1.8

1.6

—

(4133840)

1.33

0.37

1.3

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

582

1.12

0.36

1.1

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

407

0.86

0.36

1.3

1.6

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

407

0.86

0.36

2.6

3.3

nmol/l

5.0

19.4

0.54

396

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

263

1.18

0.35

2.0

2.6

e6/l

622.0

687.7

0.16

112

(40757373) Influenza virus identified in Isolate

0.65

0.35

1.8

1.7

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.36

0.34

1.0

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

109

1007

1.08

0.34

1.4

2.3

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

100

1.30

0.33

1.2

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

409

3940

1.04

0.33

1.6

—

(3042733) HLA Ab [Presence] in Serum

133

0.75

0.33

3.1

4.9

—

(4198724)

155

0.77

0.33

1.6

2.9

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

123

1145

1.08

0.32

1.8

2.1

90.2

91.7

0.28

116

1066

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

316

0.85

0.31

1.7

1.5

g/l

1.0

0.29

316

(3020779) Urea [Moles/volume] in Serum or Plasma

309

2964

1.05

0.31

7.0

8.2

mmol/l

10.2

9.4

1.04

299

2841

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

466

1.12

0.30

6.9

6.7

mg/l

12.2

11.5

0.50

436

(4146454)

362

1.13

0.30

2.8

2.6

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

114

1063

1.07

0.30

2.9

3.2

u/ml

0.3

0.62

588

(4015189)

1.31

0.30

3.2

2.5

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

259

1.16

0.29

1.1

1.3

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

141

0.78

0.29

3.0

2.5

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

493

0.89

0.29

1.0

1.1

u/ml

4.4

2.7

—

182

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.23

0.29

1.6

2.0

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

233

2226

1.05

0.29

2.6

3.4

pmol/l

4.5

0.04

205

1998

(40768806) Pleura Pathology biopsy report

308

1.14

0.27

1.6

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

194

0.82

0.27

1.3

1.2

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

1.21

0.26

1.1

1.3

—

121.3

—

(40765096) Chromosome analysis panel by Banding

113

1.24

0.26

1.4

1.1

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

126

1188

1.06

0.25

3.3

3.6

u/ml

1177.9

2114.6

0.33

107

1020

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

273

1.14

0.25

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

622

0.92

0.24

1.2

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

622

0.92

0.24

1.2

1.1

—

(3003338) MCHC [Mass/volume]

3062

30445

1.02

0.24

30.1

16.8

g/l

332.0

332.8

6.28

3051

30246

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.32

0.23

1.2

umol/24h

1.8

—

(3044007) Cell count panel - Peritoneal fluid

106

1.23

0.23

1.7

2.2

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

403

4144

0.97

0.23

4.3

4.4

31.0

31.8

0.65

303

2882

(3023511) Choriogonadotropin [Units/volume] in Urine

505

1.09

0.23

1.4

1.3

—

(4268621)

400

0.90

0.22

2.4

2.3

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

293

2835

1.04

0.22

2.1

2.2

nmol/l

13.0

13.4

0.39

253

2528

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.74

0.22

1.0

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

0.74

0.22

1.1

—

(40768795) Lymph node Pathology biopsy report

347

0.89

0.22

1.2

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.22

0.22

1.0

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

132

1255

1.05

0.22

1.6

1.5

—

(4094501)

110

1041

1.06

0.21

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

513

0.92

0.21

1.3

1.4

nmol/l

0.3

0.06

391

(3038385) Creatinine [Moles/volume] in Peritoneal fluid

0.00

0.21

0.0

1.3

—

176.7

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.3

—

2.3

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

0.21

0.0

1.0

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

594

1.08

0.21

1.3

1.2

u/ml

3.1

3.6

0.08

192

(3043409) Potassium [Moles/volume] in Arterial blood

104

983

1.06

0.21

5.1

4.4

mmol/l

3.9

0.06

930

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

188

0.85

0.21

3.7

6.6

u/ml

—

171.4

—

(3020618) Glucose [Moles/volume] in Synovial fluid

0.00

0.21

0.0

1.1

—

5.8

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.3

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.21

0.0

1.0

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

209

0.86

0.21

1.2

1.4

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.21

0.0

1.1

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.00

0.20

0.0

1.4

—

1.8

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

0.00

0.20

0.0

1.0

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.20

0.0

1.0

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

442

1.09

0.19

1.2

1.1

—

(3012565) Volume of 24 hour Urine

193

1.14

0.19

1.6

2.6

2183.7

1892.7

0.82

175

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.13

0.18

1.2

1.1

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.17

0.17

1.4

1.8

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

116

1211

0.96

0.16

1.3

1.4

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.14

0.16

3.0

1.5

—

(3011648) Oxygen content in Venous blood

286

0.91

0.15

2.0

2.2

10.0

11.3

1.10

286

(3003888) Timothy IgE Ab [Units/volume] in Serum

605

0.94

0.15

1.1

u/ml

4.0

4.6

0.08

295

(3020191) Ethanol [Moles/volume] in Serum or Plasma

306

0.91

0.14

1.4

1.5

promille

1.3

0.04

238

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

409

0.93

0.14

2.4

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

870

8802

0.99

0.14

3.7

3.9

21.6

21.4

0.14

368

3964

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.83

0.13

10.1

2.6

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.83

0.13

10.1

2.6

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

103

1.17

0.13

1.0

1.1

—

3.1

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

187

1818

1.03

0.13

7.6

10.9

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

108

1039

1.04

0.13

2.4

186.6

187.6

0.04

100

990

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

180

0.89

0.13

1.2

1.1

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

180

1.11

0.13

1.2

1.7

u/field

1.3

3.0

0.98

137

(3003694) ABO and Rh group [Type] in Blood

965

9556

1.01

0.12

1.4

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

424

4172

1.02

0.12

7.1

6.4

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

210

1.10

0.12

2.3

1.7

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

477

0.94

0.12

1.3

mmol/l

9.2

7.2

2.37

356

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

162

1.11

0.11

1.0

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

182

1775

1.03

0.11

1.1

1.0

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

101

975

1.04

0.11

1.3

u/l

10.0

10.3

0.05

792

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

690

0.96

0.11

1.2

1.1

u/ml

0.5

1.6

2.09

263

(3017704) Immunofixation for Urine

182

1.10

0.11

1.3

1.7

—

(3045142) Bone marrow Pathology biopsy report

383

0.94

0.10

1.3

1.4

—

(3028707) Methadone [Presence] in Urine by Screen method

565

1.04

0.09

1.6

3.0

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

135

1.11

0.09

1.1

7.1

mg/l

68.4

60.6

—

103

(3008401) Mugwort IgE Ab [Units/volume] in Serum

585

0.96

0.09

1.1

u/ml

1.4

1.3

0.02

233

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

1.06

0.09

2.8

2.3

pmol/l

60.4

82.1

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.07

0.08

1.7

ng/l

181.5

120.5

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

334

3386

0.99

0.08

3.1

4.2

ug/l

13.6

24.5

0.80

274

2725

(3027008) Opiates [Presence] in Urine

133

1299

1.02

0.08

1.4

2.0

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

0.83

0.08

1.0

1.7

pmol/l

30.6

40.6

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.14

0.08

7.2

7.9

—

(3047189) Immunofixation for 24 hour Urine

166

1.08

0.07

1.9

1.8

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

0.86

0.07

1.5

2.2

umol/l

14.4

17.2

—

(3008536) Aspergillus sp Ab [Presence] in Serum

0.80

0.07

1.0

2.0

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

0.85

0.07

1.1

—

(3000764) Benzodiazepines [Presence] in Urine

132

1293

1.02

0.07

1.4

2.2

—

(3006653) Thiamine [Moles/volume] in Blood

196

1.07

0.07

1.3

nmol/l

146.7

136.7

0.60

196

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

377

0.95

0.07

2.4

2.3

mg/l

30.9

23.0

0.31

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.05

0.07

1.2

1.1

—

(3028300) Cannabinoids [Presence] in Urine

133

1304

1.02

0.06

1.4

2.2

—

(4306422)

579

0.97

0.06

1.2

—

(3035933) Granulocytes/100 leukocytes in Blood

105

0.86

0.06

1.4

1.6

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

178

1.07

0.05

1.2

1.4

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

577

0.97

0.05

1.3

1.2

u/ml

6.2

4.7

0.30

251

(4027681)

232

0.95

0.05

1.2

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

160

1.06

0.04

1.9

1.8

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

826

8227

1.01

0.04

2.4

2.3

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

299

1.04

0.03

1.1

1.2

mg/l

38.0

41.7

0.21

246

(3024891) Influenza virus A+B Ag [Presence] in Specimen

935

1.02

0.03

1.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

210

1.05

0.03

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

191

1.05

0.03

1.4

1.3

—

(3019832) Treponema pallidum Ab [Presence] in Serum

277

2753

1.01

0.02

1.6

—

(3025130) Human papilloma virus identified in Specimen

460

1.02

0.02

1.6

1.8

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

202

1.04

0.02

1.1

1.0

u/ml

9.0

0.8

—

(3016879) Cocaine [Presence] in Urine

121

1200

1.01

0.01

1.4

2.3

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

173

1.04

0.01

1.2

1.4

—

(3035637) Corticotropin [Mass/volume] in Plasma

427

0.98

0.01

1.5

1.6

—

(3033799) Differential panel - Peritoneal fluid

114

1.05

0.00

2.9

2.1

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

134

1.04

0.00

1.4

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

166

0.96

0.00

1.4

1.6

mmol/l

9.5

7.9

—

(3047181) Lactate [Moles/volume] in Blood

104

1046

0.99

0.00

4.2

6.9

mmol/l

1.3

0.21

917

(3027944) Amphetamines [Presence] in Urine

128

1274

1.00

0.00

1.4

2.1

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

118

1.02

0.00

2.8

2.1

e6/l

357.3

20199.9

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

132

0.98

0.00

1.2

1.1

—

(3024932) HLA-DR beta [Type]

132

0.98

0.00

1.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

208

1.01

0.00

1.1

1.0

u/ml

26.8

3.4

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

105

0.95

0.00

1.1

1.2

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

125

1.04

0.00

1.2

1.1

—

(3024471) HLA-A [Type]

135

1.04

0.00

1.0

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

358

1.01

0.00

1.1

—

(40757494) Bilirubin.total [Moles/volume] in Blood

175

1.03

0.00

2.1

2.6

—

25.7

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

104

0.96

0.00

1.0

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

134

0.97

0.00

1.2

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

134

0.97

0.00

1.2

1.4

—

(3051593) INR in Capillary blood by Coagulation assay

136

1.03

0.00

7.4

11.9

—

(3034426) Prothrombin time (PT)

136

1.03

0.00

1.2

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

216

1.02

0.00

2.9

2.8

45.3

40.7

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

456

1.01

0.00

1.9

1.8

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

233

0.99

0.00

1.1

1.2

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

514

0.99

0.00

1.2

1.4

u/l

21.7

29.0

1.24

423

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

251

1.00

0.00

1.5

1.7

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

696

1.01

0.00

2.9

3.6

u/ml

73.5

725.0

1.09

643

(40758292) HTLV I+II Ab panel - Serum

1.00

0.00

1.7

1.4

—

(3052912) Proteinase 3 IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

0.0

1.1

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

0.00

0.0

2.3

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

0.00

0.0

1.0

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

0.95

0.00

7.2

7.8

—

(40765089) Chromosome analysis panel - Blood by G-banded

0.96

0.00

1.0

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.97

0.00

1.0

—

(3017400) Magnesium [Moles/volume] in Urine

0.00

0.0

1.0

—

2.1

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.0

7.3

—

0.3

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.00

0.0

5.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

0.93

0.00

2.2

1.8

—

(3016135) IgD [Mass/volume] in Serum

0.00

0.0

1.3

—

110.7

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.00

0.0

1.7

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.0

1.2

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

0.00

0.0

2.0

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

0.90

0.00

1.2

1.3

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.0

1.0

—

(3009992) Blasts/100 cells in Bone marrow

0.00

0.0

2.2

—

2.6

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

0.00

0.0

1.5

—

(3052592) Norovirus Ag [Presence] in Stool

0.93

0.00

1.4

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

0.00

0.0

1.4

—

2001.4

—

(3036180) Methadone [Presence] in Urine

0.00

0.0

2.9

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

0.0

1.0

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.01

0.00

7.9

8.1

—

(36303858) Crystals [Presence] in Urine

0.00

0.0

1.0

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

0.00

0.0

1.3

—

649.5

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

0.0

1.0

—

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

0.00

0.0

1.0

—

1289.3

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.02

0.00

1.2

1.3

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

0.00

0.0

7.3

—

124.9

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3028714) Urate [Moles/time] in 24 hour Urine

0.00

0.0

1.3

—

(3047185) IgG [Mass/volume] in Urine

0.00

0.0

1.0

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

0.0

1.0

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

0.0

1.0

—

2.0

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

0.00

0.0

1.2

—

(3041806) Other cells [#/volume] in Blood by Manual count

0.92

0.00

2.0

1.5

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.0

1.3

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: PSOR_ARTHR_OTH – Other psoriatic arthropathies

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Other psoriatic arthropathies

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Other psoriatic arthropathies (PSOR_ARTHR_OTH)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints